[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0565665T3 - Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider - Google Patents

Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider

Info

Publication number
DK0565665T3
DK0565665T3 DK92921544T DK92921544T DK0565665T3 DK 0565665 T3 DK0565665 T3 DK 0565665T3 DK 92921544 T DK92921544 T DK 92921544T DK 92921544 T DK92921544 T DK 92921544T DK 0565665 T3 DK0565665 T3 DK 0565665T3
Authority
DK
Denmark
Prior art keywords
prothrombin time
recombinant human
preparation
human factor
synthetic phospholipids
Prior art date
Application number
DK92921544T
Other languages
English (en)
Inventor
Pamela L Hawkins
Liliana Tejidor
James Maynard
Kevin B Johnson
Original Assignee
Dade Behring Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Inc filed Critical Dade Behring Inc
Application granted granted Critical
Publication of DK0565665T3 publication Critical patent/DK0565665T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK92921544T 1991-10-04 1992-09-25 Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider DK0565665T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77129491A 1991-10-04 1991-10-04
PCT/US1992/008281 WO1993007492A1 (en) 1991-10-04 1992-09-25 Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids

Publications (1)

Publication Number Publication Date
DK0565665T3 true DK0565665T3 (da) 1998-09-28

Family

ID=25091357

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92921544T DK0565665T3 (da) 1991-10-04 1992-09-25 Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider

Country Status (11)

Country Link
US (1) US5625036A (da)
EP (1) EP0565665B1 (da)
JP (1) JP3416778B2 (da)
AT (1) ATE163768T1 (da)
AU (1) AU663343B2 (da)
CA (1) CA2097199C (da)
DE (1) DE69224622T2 (da)
DK (1) DK0565665T3 (da)
ES (1) ES2115679T3 (da)
NZ (1) NZ244597A (da)
WO (1) WO1993007492A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418141A (en) * 1994-05-06 1995-05-23 Avocet Medical, Inc. Test articles for performing dry reagent prothrombin time assays
IL115849A0 (en) * 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
AT403437B (de) * 1995-02-15 1998-02-25 Immuno Ag Physiologisch aktive gewebefaktor-präparation
JP2000500348A (ja) * 1995-11-22 2000-01-18 オゥクラホゥマ、メディカル、リサーチ、ファウンデイシャン 血液凝固第▲viii▼因子および第▲ix▼因子のアッセイ
US5858724A (en) * 1996-07-16 1999-01-12 Pel-Freez Recombinant rabbit tissue factor
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
CA2288058A1 (en) * 1997-04-23 1998-10-29 Instrumentation Laboratory, S.P.A. Recombinant rabbit tissue factor based prothrombin time reagent
AU9114598A (en) * 1997-08-26 1999-03-16 University Of North Carolina At Chapel Hill, The Method of monitoring blood low molecular weight heparin and heparin
US6245573B1 (en) 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
EP1031830B8 (fr) 1999-02-23 2009-12-09 Asulab S.A. Système électrochimique pour la détermination d'un temps de coagulation du sang
US6733985B1 (en) * 1999-05-19 2004-05-11 International Technidyne Corporation Preparation of stable liquid and dried synthetic prothrombin time reagents
US6699718B1 (en) * 1999-09-03 2004-03-02 Roche Diagnostics Corporation Method, reagent and test cartridge for determining clotting time
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US6645768B1 (en) * 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
US6743596B1 (en) 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US6596543B2 (en) 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
US7358337B2 (en) * 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin
US7049087B2 (en) * 2002-11-05 2006-05-23 Lifescan, Inc. Method for manufacturing a tissue factor-based prothrombin time reagent
EP1561094A4 (en) * 2002-11-12 2008-11-19 Inverness Medical Switzerland PHOTOMETRIC DETERMINATION OF COOLING TIME IN UNFORINISHED FULL BLOOD
AU2003290663A1 (en) * 2002-11-13 2004-06-03 Haematologic Technologies, Inc. Assay for tissue factor and factor viia
US20050221414A1 (en) * 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
US7148067B2 (en) 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
CN101151533A (zh) * 2005-02-16 2008-03-26 伊利诺斯大学理事会 基于金属螯合脂质的促凝血剂
AT501650A1 (de) * 2005-02-22 2006-10-15 Technoclone Ges M B H Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
CN101184775A (zh) 2005-03-04 2008-05-21 伊利诺斯大学理事会 凝血及纤溶级联系统的调控剂
JP5073270B2 (ja) 2006-11-14 2012-11-14 シスメックス株式会社 凝固検査用試薬及びその製造方法
EP2040073A1 (en) 2007-09-20 2009-03-25 Iline Microsystems, S.L. Microfluidic device and method for fluid clotting time determination
US8821861B2 (en) 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) * 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
WO2011144953A1 (en) * 2010-05-18 2011-11-24 Diagon Kft. Procedure for producing recombinant human tissue factor
RU2567746C2 (ru) 2010-05-28 2015-11-10 ДИАГОН Кфт. Способ двухфазного получения липосом и способы их применения при изготовлении диагностических реагентов
CN102608337B (zh) * 2011-04-22 2014-05-14 武汉塞力斯生物技术有限公司 凝血酶原时间测定试剂盒及其制备方法
CN112481355B (zh) * 2020-11-16 2023-05-30 武汉市长立生物技术有限责任公司 液体型凝血酶原时间测定试剂盒及其制备方法
CN115508569A (zh) * 2022-09-15 2022-12-23 上海太阳生物技术有限公司 蛋白s试剂及检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289498A (en) * 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4461833A (en) * 1982-06-23 1984-07-24 University Patents, Inc. Chromatographically purifying proteolytic procoagulant enzyme from animal tissue extract
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
SE458342B (sv) * 1987-07-06 1989-03-20 Alfa Laval Ab Centrifugalseparator innefattande en rotor med en separeringskammare bestaaende av tvaa avdelningar
US4865984A (en) * 1988-02-08 1989-09-12 Mount Sinai School Of Medicine Of The City University Of New York Dynamic continuous flow enzyme reactor
US5472850A (en) * 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent

Also Published As

Publication number Publication date
JPH06505562A (ja) 1994-06-23
NZ244597A (en) 1993-09-27
CA2097199C (en) 2001-05-08
DE69224622T2 (de) 1998-11-05
JP3416778B2 (ja) 2003-06-16
WO1993007492A1 (en) 1993-04-15
DE69224622D1 (de) 1998-04-09
ES2115679T3 (es) 1998-07-01
US5625036A (en) 1997-04-29
AU2769292A (en) 1993-05-03
EP0565665B1 (en) 1998-03-04
ATE163768T1 (de) 1998-03-15
AU663343B2 (en) 1995-10-05
CA2097199A1 (en) 1993-04-05
EP0565665A1 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
DK0565665T3 (da) Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider
Shomers et al. Properties of cysteine-containing phosphoproteins from human submandibular-sublingual saliva
ATE83927T1 (de) Thrombinzusammensetzung.
DE68918155D1 (de) Chirurgisches Klebstoffmaterial.
AT338429B (de) Zur verankerung von implantaten und gelenkendoprothesen im knochen dienende mischung
DK0527798T3 (da) Fremgangsmåde og sammensætning til behandling af thrombose
DE69118535D1 (de) Osteo-induktive pharmazeutische formulierungen
DE3752372D1 (de) Verfahren zur regulierung der metabolischen stabilität von proteinen
DE3484933D1 (de) Implantat zur befestigung von zahnprothesen.
ES2063965T3 (es) Vacunas para haemophilus influenzae no tipificable.
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
UA39174C2 (uk) Асоціати депротонованої гіалуронової кислоти, спосіб одержання асоціатів депротонованої гіалуронової кислоти, фармацевтична композиція та спосіб одержання фармацевтичної композиції
ATE89740T1 (de) Verfahren zur herstellung und zusammensetzungen von kollagen-derivaten.
AT388096B (de) Implantat zur befestigung von zahnprothesen
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
ATE78042T1 (de) Analoge des humanen relaxins.
DE3486081D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxid.
DE3855810D1 (de) Dispersion von Kalzium-Karbonat in Glycol
FI930266A (fi) Vateriitti ja menetelmä sen valmistamiseksi
DE69306915D1 (de) Kombination zur Detektion von Weichgewebeanomalien
NO912888D0 (no) Fremgangsmaate for fremstilling av nye peperidylethere og -thioethere.
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
AR014119A1 (es) Utilizacion de cetolidas para la fabricacion de composiciones farmaceuticas destinadas a prevenir complicaciones tromboticas arteriales asociadas a laaterosclerosis
Psuja et al. Binding of heparin to human endothelial cell monolayer and extracellular matrix in culture